Clinical Trial Update: Evaluation of Consistency of StaphVAX Manufacturing Lots [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the consistency of StaphVAX manufacturing lots. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcal Infections

Drugs mentioned

• StaphVAX

Snippet

Sponsor: Nabi Biopharmaceuticals | Conditions: Staphylococcal Infections | Phase 3 | Status: COMPLETED